Corealis Pharma Inc.

CDMO

Canada

https://www.corealispharma.com/

Is this your company? Claim this profile

Drug Product

Analytical & Bioanalytical Services

Clinical Trial Supply & Logistics

Company Overview

About

Corealis Pharma Inc. is a pharmaceutical CDMO offering comprehensive services.

Key Expertise

Specialized in API Manufacturing, Sterile Fill/Finish, Lyophilization

Therapeutic Areas

Neurology

Quick Facts

HQ:Canada

Founded:1991

Employees:2,218

Capabilities & Services

Core Capabilities

Cytotoxic / ADC Handling
High-Potency API
Sterile Fill/Finish

Types of Organization

GMP Manufacturing

Quality Systems

Regulatory Support

Dosage Forms

Topical / Transdermal

Containment Capabilities

BSL-2 (Biosafety Level 2)

Production Scales

Phase III Clinical Trials

Commercial Scale

Clinical

Markets Served

Europe

Regulatory Approvals

Drug Approval 4SPOQ3

PMDA · #APR-CSJKDG3N · 2022-03-01

Certifications

MHRA GMP

UK Medicines and Healthcare products Regulatory Agency

Cert #: CERT-ANFBLN6Q

Issued: 2020-04-09

Expires: 2025-10-15

Health Canada GMP

Health Canada

Cert #: CERT-BVN0AI1N

Issued: 2020-11-03

Expires: 2025-08-17

EMA GMP Certificate

European Medicines Agency

Cert #: CERT-B4V797FI

Issued: 2020-10-05

Expires: 2025-03-04

FDA Registration

U.S. Food and Drug Administration

Cert #: CERT-F4B8866B

Issued: 2020-05-20

Expires: 2025-05-03

Loading CDMO intelligence...

Request an Introduction

Please log in to contact this provider.

Key facts about Corealis Pharma Inc.

Corealis Pharma Inc. is headquartered in Canada.
Corealis Pharma Inc. was founded in 1991.
Corealis Pharma Inc. has 2,218 employees.
Corealis Pharma Inc.'s capabilities include Cytotoxic / ADC Handling, High-Potency API and Sterile Fill/Finish.

Find CDMOs like Corealis Pharma Inc.

Directory pages this company appears in, each with the full list of matching manufacturers.

CDMOs in Canada CDMOs in North America Fill-Finish CDMOs Topical / Transdermal CDMOs BSL-2 (Biosafety Level 2) CDMOs